Authors:
Voderholzer, U
Riemann, D
Hornyak, M
Backhaus, J
Feige, B
Berger, M
Hohagen, F
Citation: U. Voderholzer et al., A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects, EUR ARCH PS, 251(3), 2001, pp. 117-123
Authors:
Backhaus, J
Hohagen, F
Voderholzer, U
Riemann, D
Citation: J. Backhaus et al., Long-term effectiveness of a short-term cognitive-behavioral group treatment for primary insomnia, EUR ARCH PS, 251(1), 2001, pp. 35-41
Authors:
Hajak, G
Rodenbeck, A
Voderholzer, U
Riemann, D
Cohrs, S
Hohagen, F
Berger, M
Ruther, E
Citation: G. Hajak et al., Doxepin in the treatment of primary insomnia: A placebo-controlled, double-blind, polysomnographic study, J CLIN PSY, 62(6), 2001, pp. 453-463
Authors:
Weske, G
Berger, M
Riemann, D
Voderholzer, U
Citation: G. Weske et al., Neurobiological findings in a patient with 48-hour manic-depressive cycles. A case study, NERVENARZT, 72(7), 2001, pp. 549-554
Authors:
Wichniak, A
Riemann, D
Kiemen, A
Voderholzer, U
Jernajczyk, W
Citation: A. Wichniak et al., Comparison between eye movement latency and REM sleep parameters in major depression, EUR ARCH PS, 250(1), 2000, pp. 48-52
Authors:
Riemann, D
Konig, A
Hohagen, F
Kiemen, A
Voderholzer, U
Backhaus, J
Bunz, J
Wesiack, B
Hermle, L
Berger, M
Citation: D. Riemann et al., How to preserve the antidepressive effect of sleep deprivation: A comparison of sleep phase advance and sleep phase delay, EUR ARCH PS, 249(5), 1999, pp. 231-237